Clinical Trial Update: A Clinical Study on the Benefits of Carbon Nanoparticles Injection Time in Patients With Thyroid Cancer. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the timing of carbon nanoparticles injection in papillary thyroid cancer; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Papillary Thyroid Cancer

Drugs mentioned

• Carbon Nanoparticles (carbon nanoparticles)

Snippet

Sponsor: Second Affiliated Hospital of Xi'an Jiaotong University | Conditions: Papillary Thyroid Cancer | Phase 3 | Status: RECRUITING